Intuitive Surgical (NSDQ:ISRG) said yesterday it submitted a premarket notification application to the FDA seeking clearance for its new flexible, robotic-assisted catheter-based platform intended for use in the lungs.
The new platform is designed for navigation through very small lung airways to reach peripheral nodules for biopsies, the Sunnyvale, Calif.-based company said in a press release.
Intuitive Surgical did not release any other details of the tools.
In July, Intuitive Surgical saw shares rise in after-hours trading after the robotic surgical platform maker beat expectations on Wall Street with its second quarter results.